nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—pancreatic cancer	0.54	1	CbGaD
Clodronate—SLC25A6—islet of Langerhans—pancreatic cancer	0.00961	0.184	CbGeAlD
Clodronate—SLC25A5—islet of Langerhans—pancreatic cancer	0.00836	0.16	CbGeAlD
Clodronate—SLC25A6—pancreas—pancreatic cancer	0.00675	0.13	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Gemcitabine—pancreatic cancer	0.00631	1	CbGdCrCtD
Clodronate—SLC25A5—pancreas—pancreatic cancer	0.00588	0.113	CbGeAlD
Clodronate—SLC25A6—digestive system—pancreatic cancer	0.00577	0.111	CbGeAlD
Clodronate—SLC25A5—digestive system—pancreatic cancer	0.00502	0.0963	CbGeAlD
Clodronate—SLC25A4—digestive system—pancreatic cancer	0.0047	0.0902	CbGeAlD
Clodronate—PTGS2—gall bladder—pancreatic cancer	0.0024	0.0461	CbGeAlD
Clodronate—PTGS2—islet of Langerhans—pancreatic cancer	0.00157	0.0302	CbGeAlD
Clodronate—PTGS2—pancreas—pancreatic cancer	0.00111	0.0212	CbGeAlD
Clodronate—PTGS2—digestive system—pancreatic cancer	0.000945	0.0181	CbGeAlD
Clodronate—Local reaction—Epirubicin—pancreatic cancer	0.000915	0.00345	CcSEcCtD
Clodronate—Blood creatinine increased—Sunitinib—pancreatic cancer	0.000897	0.00338	CcSEcCtD
Clodronate—Dehydration—Sunitinib—pancreatic cancer	0.00089	0.00335	CcSEcCtD
Clodronate—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.000879	0.00331	CcSEcCtD
Clodronate—Abdominal pain upper—Sunitinib—pancreatic cancer	0.000874	0.00329	CcSEcCtD
Clodronate—Pneumonia—Tamoxifen—pancreatic cancer	0.000866	0.00326	CcSEcCtD
Clodronate—Extravasation—Docetaxel—pancreatic cancer	0.000861	0.00324	CcSEcCtD
Clodronate—Pneumonia—Erlotinib—pancreatic cancer	0.000857	0.00323	CcSEcCtD
Clodronate—Renal failure acute—Irinotecan—pancreatic cancer	0.000854	0.00322	CcSEcCtD
Clodronate—Local reaction—Doxorubicin—pancreatic cancer	0.000846	0.00319	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.000844	0.00318	CcSEcCtD
Clodronate—Renal failure—Erlotinib—pancreatic cancer	0.000838	0.00316	CcSEcCtD
Clodronate—Renal impairment—Irinotecan—pancreatic cancer	0.000828	0.00312	CcSEcCtD
Clodronate—Dysphagia—Sunitinib—pancreatic cancer	0.000827	0.00312	CcSEcCtD
Clodronate—Serum creatinine increased—Epirubicin—pancreatic cancer	0.000823	0.0031	CcSEcCtD
Clodronate—Oliguria—Docetaxel—pancreatic cancer	0.000815	0.00307	CcSEcCtD
Clodronate—Renal impairment—Gemcitabine—pancreatic cancer	0.000807	0.00304	CcSEcCtD
Clodronate—Cardiac failure—Gemcitabine—pancreatic cancer	0.000787	0.00297	CcSEcCtD
Clodronate—Cardiac failure—Fluorouracil—pancreatic cancer	0.000774	0.00292	CcSEcCtD
Clodronate—Pharyngitis—Tamoxifen—pancreatic cancer	0.000767	0.00289	CcSEcCtD
Clodronate—Serum creatinine increased—Doxorubicin—pancreatic cancer	0.000762	0.00287	CcSEcCtD
Clodronate—Urinary tract disorder—Erlotinib—pancreatic cancer	0.000755	0.00285	CcSEcCtD
Clodronate—Connective tissue disorder—Erlotinib—pancreatic cancer	0.000752	0.00283	CcSEcCtD
Clodronate—Hepatocellular injury—Docetaxel—pancreatic cancer	0.000751	0.00283	CcSEcCtD
Clodronate—Urethral disorder—Erlotinib—pancreatic cancer	0.00075	0.00283	CcSEcCtD
Clodronate—Pneumonia—Sunitinib—pancreatic cancer	0.000742	0.0028	CcSEcCtD
Clodronate—Blood creatinine increased—Irinotecan—pancreatic cancer	0.000739	0.00278	CcSEcCtD
Clodronate—Dehydration—Irinotecan—pancreatic cancer	0.000733	0.00276	CcSEcCtD
Clodronate—Hypercalcaemia—Epirubicin—pancreatic cancer	0.000729	0.00275	CcSEcCtD
Clodronate—Renal failure—Sunitinib—pancreatic cancer	0.000725	0.00273	CcSEcCtD
Clodronate—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00072	0.00271	CcSEcCtD
Clodronate—Mediastinal disorder—Erlotinib—pancreatic cancer	0.000689	0.0026	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000677	0.00255	CcSEcCtD
Clodronate—Hypercalcaemia—Doxorubicin—pancreatic cancer	0.000674	0.00254	CcSEcCtD
Clodronate—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000654	0.00246	CcSEcCtD
Clodronate—Bronchospasm—Gemcitabine—pancreatic cancer	0.000653	0.00246	CcSEcCtD
Clodronate—Dysphagia—Fluorouracil—pancreatic cancer	0.000653	0.00246	CcSEcCtD
Clodronate—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000651	0.00245	CcSEcCtD
Clodronate—Urethral disorder—Sunitinib—pancreatic cancer	0.000649	0.00245	CcSEcCtD
Clodronate—Anaemia—Tamoxifen—pancreatic cancer	0.000622	0.00234	CcSEcCtD
Clodronate—Angioedema—Tamoxifen—pancreatic cancer	0.000615	0.00232	CcSEcCtD
Clodronate—Pneumonia—Irinotecan—pancreatic cancer	0.000611	0.0023	CcSEcCtD
Clodronate—Renal failure—Irinotecan—pancreatic cancer	0.000597	0.00225	CcSEcCtD
Clodronate—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000597	0.00225	CcSEcCtD
Clodronate—Pneumonia—Gemcitabine—pancreatic cancer	0.000595	0.00224	CcSEcCtD
Clodronate—Neoplasm malignant—Epirubicin—pancreatic cancer	0.000593	0.00223	CcSEcCtD
Clodronate—Pneumonia—Fluorouracil—pancreatic cancer	0.000585	0.00221	CcSEcCtD
Clodronate—Renal failure—Gemcitabine—pancreatic cancer	0.000582	0.00219	CcSEcCtD
Clodronate—Extravasation—Epirubicin—pancreatic cancer	0.00058	0.00219	CcSEcCtD
Clodronate—Renal impairment—Docetaxel—pancreatic cancer	0.000573	0.00216	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000563	0.00212	CcSEcCtD
Clodronate—Cardiac failure—Docetaxel—pancreatic cancer	0.000558	0.0021	CcSEcCtD
Clodronate—Hypocalcaemia—Epirubicin—pancreatic cancer	0.000553	0.00208	CcSEcCtD
Clodronate—Oliguria—Epirubicin—pancreatic cancer	0.00055	0.00207	CcSEcCtD
Clodronate—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.000549	0.00207	CcSEcCtD
Clodronate—Infection—Tamoxifen—pancreatic cancer	0.000546	0.00206	CcSEcCtD
Clodronate—Infection—Erlotinib—pancreatic cancer	0.00054	0.00203	CcSEcCtD
Clodronate—Extravasation—Doxorubicin—pancreatic cancer	0.000537	0.00202	CcSEcCtD
Clodronate—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000536	0.00202	CcSEcCtD
Clodronate—Anaemia—Sunitinib—pancreatic cancer	0.000533	0.00201	CcSEcCtD
Clodronate—Creatinine increased—Epirubicin—pancreatic cancer	0.000532	0.002	CcSEcCtD
Clodronate—Skin disorder—Erlotinib—pancreatic cancer	0.000528	0.00199	CcSEcCtD
Clodronate—Pharyngitis—Gemcitabine—pancreatic cancer	0.000527	0.00199	CcSEcCtD
Clodronate—Angioedema—Sunitinib—pancreatic cancer	0.000527	0.00198	CcSEcCtD
Clodronate—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000525	0.00198	CcSEcCtD
Clodronate—Anorexia—Tamoxifen—pancreatic cancer	0.000524	0.00197	CcSEcCtD
Clodronate—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000522	0.00197	CcSEcCtD
Clodronate—Urethral disorder—Gemcitabine—pancreatic cancer	0.000521	0.00196	CcSEcCtD
Clodronate—Pharyngitis—Fluorouracil—pancreatic cancer	0.000518	0.00195	CcSEcCtD
Clodronate—Anorexia—Erlotinib—pancreatic cancer	0.000518	0.00195	CcSEcCtD
Clodronate—Hypocalcaemia—Doxorubicin—pancreatic cancer	0.000512	0.00193	CcSEcCtD
Clodronate—Oliguria—Doxorubicin—pancreatic cancer	0.000508	0.00192	CcSEcCtD
Clodronate—Dehydration—Docetaxel—pancreatic cancer	0.000507	0.00191	CcSEcCtD
Clodronate—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000506	0.00191	CcSEcCtD
Clodronate—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000498	0.00188	CcSEcCtD
Clodronate—Creatinine increased—Doxorubicin—pancreatic cancer	0.000492	0.00186	CcSEcCtD
Clodronate—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000492	0.00185	CcSEcCtD
Clodronate—Dyspnoea—Tamoxifen—pancreatic cancer	0.00049	0.00185	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000487	0.00184	CcSEcCtD
Clodronate—Dyspnoea—Erlotinib—pancreatic cancer	0.000485	0.00183	CcSEcCtD
Clodronate—Dyspepsia—Tamoxifen—pancreatic cancer	0.000484	0.00182	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000481	0.00181	CcSEcCtD
Clodronate—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000479	0.0018	CcSEcCtD
Clodronate—Dyspepsia—Erlotinib—pancreatic cancer	0.000478	0.0018	CcSEcCtD
Clodronate—Decreased appetite—Tamoxifen—pancreatic cancer	0.000477	0.0018	CcSEcCtD
Clodronate—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000474	0.00179	CcSEcCtD
Clodronate—Decreased appetite—Erlotinib—pancreatic cancer	0.000472	0.00178	CcSEcCtD
Clodronate—Dysphagia—Docetaxel—pancreatic cancer	0.000471	0.00178	CcSEcCtD
Clodronate—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000469	0.00177	CcSEcCtD
Clodronate—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000469	0.00177	CcSEcCtD
Clodronate—Infection—Sunitinib—pancreatic cancer	0.000467	0.00176	CcSEcCtD
Clodronate—Bronchospasm—Docetaxel—pancreatic cancer	0.000463	0.00175	CcSEcCtD
Clodronate—Skin disorder—Sunitinib—pancreatic cancer	0.000457	0.00172	CcSEcCtD
Clodronate—Anorexia—Sunitinib—pancreatic cancer	0.000448	0.00169	CcSEcCtD
Clodronate—Anaemia—Irinotecan—pancreatic cancer	0.000439	0.00165	CcSEcCtD
Clodronate—Urticaria—Tamoxifen—pancreatic cancer	0.000436	0.00164	CcSEcCtD
Clodronate—Abdominal pain—Tamoxifen—pancreatic cancer	0.000434	0.00164	CcSEcCtD
Clodronate—Abdominal pain—Erlotinib—pancreatic cancer	0.00043	0.00162	CcSEcCtD
Clodronate—Anaemia—Gemcitabine—pancreatic cancer	0.000427	0.00161	CcSEcCtD
Clodronate—Pneumonia—Docetaxel—pancreatic cancer	0.000422	0.00159	CcSEcCtD
Clodronate—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000421	0.00159	CcSEcCtD
Clodronate—Anaemia—Fluorouracil—pancreatic cancer	0.00042	0.00158	CcSEcCtD
Clodronate—Dyspnoea—Sunitinib—pancreatic cancer	0.000419	0.00158	CcSEcCtD
Clodronate—Dyspepsia—Sunitinib—pancreatic cancer	0.000414	0.00156	CcSEcCtD
Clodronate—Renal failure—Docetaxel—pancreatic cancer	0.000413	0.00156	CcSEcCtD
Clodronate—Decreased appetite—Sunitinib—pancreatic cancer	0.000409	0.00154	CcSEcCtD
Clodronate—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000406	0.00153	CcSEcCtD
Clodronate—Renal failure acute—Epirubicin—pancreatic cancer	0.000398	0.0015	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000391	0.00147	CcSEcCtD
Clodronate—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000389	0.00147	CcSEcCtD
Clodronate—Pruritus—Tamoxifen—pancreatic cancer	0.000389	0.00146	CcSEcCtD
Clodronate—Renal impairment—Epirubicin—pancreatic cancer	0.000386	0.00146	CcSEcCtD
Clodronate—Infection—Irinotecan—pancreatic cancer	0.000385	0.00145	CcSEcCtD
Clodronate—Pruritus—Erlotinib—pancreatic cancer	0.000384	0.00145	CcSEcCtD
Clodronate—Cardiac failure—Epirubicin—pancreatic cancer	0.000377	0.00142	CcSEcCtD
Clodronate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000376	0.00142	CcSEcCtD
Clodronate—Infection—Gemcitabine—pancreatic cancer	0.000375	0.00141	CcSEcCtD
Clodronate—Pharyngitis—Docetaxel—pancreatic cancer	0.000374	0.00141	CcSEcCtD
Clodronate—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000372	0.0014	CcSEcCtD
Clodronate—Abdominal pain—Sunitinib—pancreatic cancer	0.000372	0.0014	CcSEcCtD
Clodronate—Diarrhoea—Erlotinib—pancreatic cancer	0.000372	0.0014	CcSEcCtD
Clodronate—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000371	0.0014	CcSEcCtD
Clodronate—Urethral disorder—Docetaxel—pancreatic cancer	0.00037	0.00139	CcSEcCtD
Clodronate—Anorexia—Irinotecan—pancreatic cancer	0.000369	0.00139	CcSEcCtD
Clodronate—Infection—Fluorouracil—pancreatic cancer	0.000369	0.00139	CcSEcCtD
Clodronate—Renal failure acute—Doxorubicin—pancreatic cancer	0.000368	0.00139	CcSEcCtD
Clodronate—Skin disorder—Gemcitabine—pancreatic cancer	0.000367	0.00138	CcSEcCtD
Clodronate—Anorexia—Gemcitabine—pancreatic cancer	0.00036	0.00136	CcSEcCtD
Clodronate—Renal impairment—Doxorubicin—pancreatic cancer	0.000357	0.00135	CcSEcCtD
Clodronate—Anorexia—Fluorouracil—pancreatic cancer	0.000354	0.00133	CcSEcCtD
Clodronate—Vomiting—Tamoxifen—pancreatic cancer	0.000349	0.00132	CcSEcCtD
Clodronate—Cardiac failure—Doxorubicin—pancreatic cancer	0.000349	0.00131	CcSEcCtD
Clodronate—Rash—Tamoxifen—pancreatic cancer	0.000346	0.00131	CcSEcCtD
Clodronate—Dermatitis—Tamoxifen—pancreatic cancer	0.000346	0.0013	CcSEcCtD
Clodronate—Vomiting—Erlotinib—pancreatic cancer	0.000346	0.0013	CcSEcCtD
Clodronate—Dyspnoea—Irinotecan—pancreatic cancer	0.000345	0.0013	CcSEcCtD
Clodronate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000344	0.0013	CcSEcCtD
Clodronate—Rash—Erlotinib—pancreatic cancer	0.000343	0.00129	CcSEcCtD
Clodronate—Dermatitis—Erlotinib—pancreatic cancer	0.000342	0.00129	CcSEcCtD
Clodronate—Dehydration—Epirubicin—pancreatic cancer	0.000342	0.00129	CcSEcCtD
Clodronate—Dyspepsia—Irinotecan—pancreatic cancer	0.000341	0.00129	CcSEcCtD
Clodronate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00034	0.00128	CcSEcCtD
Clodronate—Decreased appetite—Irinotecan—pancreatic cancer	0.000337	0.00127	CcSEcCtD
Clodronate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000337	0.00127	CcSEcCtD
Clodronate—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000336	0.00127	CcSEcCtD
Clodronate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000335	0.00126	CcSEcCtD
Clodronate—Pruritus—Sunitinib—pancreatic cancer	0.000333	0.00125	CcSEcCtD
Clodronate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000331	0.00125	CcSEcCtD
Clodronate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000328	0.00124	CcSEcCtD
Clodronate—Dyspepsia—Fluorouracil—pancreatic cancer	0.000327	0.00123	CcSEcCtD
Clodronate—Nausea—Tamoxifen—pancreatic cancer	0.000326	0.00123	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000326	0.00123	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000324	0.00122	CcSEcCtD
Clodronate—Nausea—Erlotinib—pancreatic cancer	0.000323	0.00122	CcSEcCtD
Clodronate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000323	0.00122	CcSEcCtD
Clodronate—Diarrhoea—Sunitinib—pancreatic cancer	0.000322	0.00121	CcSEcCtD
Clodronate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00032	0.00121	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000319	0.0012	CcSEcCtD
Clodronate—Dysphagia—Epirubicin—pancreatic cancer	0.000318	0.0012	CcSEcCtD
Clodronate—Dehydration—Doxorubicin—pancreatic cancer	0.000316	0.00119	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000311	0.00117	CcSEcCtD
Clodronate—Abdominal pain—Irinotecan—pancreatic cancer	0.000306	0.00115	CcSEcCtD
Clodronate—Anaemia—Docetaxel—pancreatic cancer	0.000303	0.00114	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.0003	0.00113	CcSEcCtD
Clodronate—Vomiting—Sunitinib—pancreatic cancer	0.000299	0.00113	CcSEcCtD
Clodronate—Rash—Sunitinib—pancreatic cancer	0.000297	0.00112	CcSEcCtD
Clodronate—Dermatitis—Sunitinib—pancreatic cancer	0.000296	0.00112	CcSEcCtD
Clodronate—Urticaria—Fluorouracil—pancreatic cancer	0.000295	0.00111	CcSEcCtD
Clodronate—Dysphagia—Doxorubicin—pancreatic cancer	0.000294	0.00111	CcSEcCtD
Clodronate—Pneumonia—Epirubicin—pancreatic cancer	0.000285	0.00107	CcSEcCtD
Clodronate—Nausea—Sunitinib—pancreatic cancer	0.000279	0.00105	CcSEcCtD
Clodronate—Renal failure—Epirubicin—pancreatic cancer	0.000278	0.00105	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000278	0.00105	CcSEcCtD
Clodronate—Pruritus—Gemcitabine—pancreatic cancer	0.000267	0.00101	CcSEcCtD
Clodronate—Infection—Docetaxel—pancreatic cancer	0.000266	0.001	CcSEcCtD
Clodronate—Diarrhoea—Irinotecan—pancreatic cancer	0.000265	0.000999	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—pancreatic cancer	0.000264	0.000994	CcSEcCtD
Clodronate—Pruritus—Fluorouracil—pancreatic cancer	0.000263	0.00099	CcSEcCtD
Clodronate—Skin disorder—Docetaxel—pancreatic cancer	0.00026	0.000981	CcSEcCtD
Clodronate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000258	0.000973	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—pancreatic cancer	0.000258	0.000971	CcSEcCtD
Clodronate—Anorexia—Docetaxel—pancreatic cancer	0.000255	0.000962	CcSEcCtD
Clodronate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000254	0.000957	CcSEcCtD
Clodronate—Pharyngitis—Epirubicin—pancreatic cancer	0.000252	0.000951	CcSEcCtD
Clodronate—SLC25A6—Metabolism—SLC2A2—pancreatic cancer	0.000251	0.00184	CbGpPWpGaD
Clodronate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000251	0.000946	CcSEcCtD
Clodronate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00025	0.000942	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—GADD45A—pancreatic cancer	0.00025	0.00183	CbGpPWpGaD
Clodronate—Urethral disorder—Epirubicin—pancreatic cancer	0.000249	0.000939	CcSEcCtD
Clodronate—Vomiting—Irinotecan—pancreatic cancer	0.000246	0.000928	CcSEcCtD
Clodronate—SLC25A6—Disease—JAG1—pancreatic cancer	0.000244	0.00179	CbGpPWpGaD
Clodronate—Rash—Irinotecan—pancreatic cancer	0.000244	0.000921	CcSEcCtD
Clodronate—Dermatitis—Irinotecan—pancreatic cancer	0.000244	0.00092	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—HES1—pancreatic cancer	0.00024	0.00176	CbGpPWpGaD
Clodronate—Vomiting—Gemcitabine—pancreatic cancer	0.00024	0.000904	CcSEcCtD
Clodronate—SLC25A4—Disease—JAG2—pancreatic cancer	0.000239	0.00176	CbGpPWpGaD
Clodronate—Dyspnoea—Docetaxel—pancreatic cancer	0.000239	0.0009	CcSEcCtD
Clodronate—Rash—Gemcitabine—pancreatic cancer	0.000238	0.000897	CcSEcCtD
Clodronate—Dermatitis—Gemcitabine—pancreatic cancer	0.000238	0.000896	CcSEcCtD
Clodronate—Vomiting—Fluorouracil—pancreatic cancer	0.000236	0.000889	CcSEcCtD
Clodronate—Dyspepsia—Docetaxel—pancreatic cancer	0.000236	0.000889	CcSEcCtD
Clodronate—SLC25A4—Disease—MEN1—pancreatic cancer	0.000236	0.00173	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SLC2A2—pancreatic cancer	0.000234	0.00172	CbGpPWpGaD
Clodronate—Rash—Fluorouracil—pancreatic cancer	0.000234	0.000882	CcSEcCtD
Clodronate—Dermatitis—Fluorouracil—pancreatic cancer	0.000234	0.000881	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000234	0.00088	CcSEcCtD
Clodronate—Decreased appetite—Docetaxel—pancreatic cancer	0.000233	0.000878	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000232	0.000876	CcSEcCtD
Clodronate—SLC25A6—Disease—CD44—pancreatic cancer	0.000232	0.0017	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CD44—pancreatic cancer	0.000232	0.0017	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000231	0.000872	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000231	0.000871	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000231	0.00169	CbGpPWpGaD
Clodronate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000231	0.000869	CcSEcCtD
Clodronate—SLC25A6—Disease—HSPA1A—pancreatic cancer	0.000231	0.00169	CbGpPWpGaD
Clodronate—Nausea—Irinotecan—pancreatic cancer	0.00023	0.000867	CcSEcCtD
Clodronate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000229	0.000864	CcSEcCtD
Clodronate—SLC25A4—Disease—SHH—pancreatic cancer	0.000225	0.00165	CbGpPWpGaD
Clodronate—Nausea—Gemcitabine—pancreatic cancer	0.000224	0.000845	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000223	0.00164	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GCG—pancreatic cancer	0.000223	0.00163	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IAPP—pancreatic cancer	0.000222	0.00163	CbGpPWpGaD
Clodronate—Nausea—Fluorouracil—pancreatic cancer	0.00022	0.000831	CcSEcCtD
Clodronate—SLC25A5—Disease—SMAD4—pancreatic cancer	0.000219	0.00161	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HES1—pancreatic cancer	0.000214	0.00157	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HSPA1B—pancreatic cancer	0.000213	0.00156	CbGpPWpGaD
Clodronate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000212	0.000799	CcSEcCtD
Clodronate—Abdominal pain—Docetaxel—pancreatic cancer	0.000212	0.000798	CcSEcCtD
Clodronate—SLC25A4—Metabolism—GLP1R—pancreatic cancer	0.00021	0.00154	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—STK11—pancreatic cancer	0.000209	0.00154	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DPYD—pancreatic cancer	0.000207	0.00152	CbGpPWpGaD
Clodronate—Anaemia—Epirubicin—pancreatic cancer	0.000205	0.000771	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.0002	0.00147	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000198	0.00145	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatic cancer	0.000198	0.00145	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SLC2A2—pancreatic cancer	0.000196	0.00144	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CD44—pancreatic cancer	0.000195	0.00143	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JAG1—pancreatic cancer	0.000191	0.0014	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MMP2—pancreatic cancer	0.00019	0.0014	CbGpPWpGaD
Clodronate—Pruritus—Docetaxel—pancreatic cancer	0.00019	0.000714	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—pancreatic cancer	0.000189	0.000713	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatic cancer	0.000189	0.00139	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TERT—pancreatic cancer	0.000187	0.00137	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000187	0.000705	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GCG—pancreatic cancer	0.000186	0.00137	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SMAD4—pancreatic cancer	0.000183	0.00135	CbGpPWpGaD
Clodronate—Diarrhoea—Docetaxel—pancreatic cancer	0.000183	0.000691	CcSEcCtD
Clodronate—SLC25A4—Disease—CD44—pancreatic cancer	0.000181	0.00133	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HSPA1A—pancreatic cancer	0.00018	0.00132	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TYMS—pancreatic cancer	0.00018	0.00132	CbGpPWpGaD
Clodronate—Infection—Epirubicin—pancreatic cancer	0.00018	0.000676	CcSEcCtD
Clodronate—SLC25A5—Disease—HIF1A—pancreatic cancer	0.000179	0.00131	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HES1—pancreatic cancer	0.000179	0.00131	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TSC2—pancreatic cancer	0.000179	0.00131	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	0.000176	0.00129	CbGpPWpGaD
Clodronate—Skin disorder—Epirubicin—pancreatic cancer	0.000176	0.000661	CcSEcCtD
Clodronate—SLC25A6—Metabolism—STK11—pancreatic cancer	0.000175	0.00129	CbGpPWpGaD
Clodronate—SLC25A5—Disease—APOE—pancreatic cancer	0.000175	0.00128	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000173	0.000653	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000173	0.00127	CbGpPWpGaD
Clodronate—Anorexia—Epirubicin—pancreatic cancer	0.000172	0.000649	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	0.000172	0.00126	CbGpPWpGaD
Clodronate—Vomiting—Docetaxel—pancreatic cancer	0.00017	0.000642	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00017	0.00125	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	0.00017	0.00124	CbGpPWpGaD
Clodronate—Rash—Docetaxel—pancreatic cancer	0.000169	0.000636	CcSEcCtD
Clodronate—Dermatitis—Docetaxel—pancreatic cancer	0.000169	0.000636	CcSEcCtD
Clodronate—Infection—Doxorubicin—pancreatic cancer	0.000166	0.000626	CcSEcCtD
Clodronate—Skin disorder—Doxorubicin—pancreatic cancer	0.000162	0.000612	CcSEcCtD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pancreatic cancer	0.000161	0.00118	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOTCH1—pancreatic cancer	0.000161	0.00118	CbGpPWpGaD
Clodronate—Dyspnoea—Epirubicin—pancreatic cancer	0.000161	0.000607	CcSEcCtD
Clodronate—Anorexia—Doxorubicin—pancreatic cancer	0.000159	0.000601	CcSEcCtD
Clodronate—Nausea—Docetaxel—pancreatic cancer	0.000159	0.0006	CcSEcCtD
Clodronate—Dyspepsia—Epirubicin—pancreatic cancer	0.000159	0.000599	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—CXCL8—pancreatic cancer	0.000158	0.00116	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	0.000158	0.00116	CbGpPWpGaD
Clodronate—Decreased appetite—Epirubicin—pancreatic cancer	0.000157	0.000592	CcSEcCtD
Clodronate—SLC25A6—Disease—TERT—pancreatic cancer	0.000157	0.00115	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000156	0.000588	CcSEcCtD
Clodronate—SLC25A5—Disease—EGF—pancreatic cancer	0.000156	0.00114	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	0.000154	0.00113	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CD44—pancreatic cancer	0.000152	0.00111	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TYMS—pancreatic cancer	0.000151	0.00111	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HIF1A—pancreatic cancer	0.00015	0.0011	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TSC2—pancreatic cancer	0.00015	0.0011	CbGpPWpGaD
Clodronate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000149	0.000562	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—MMP2—pancreatic cancer	0.000149	0.00109	CbGpPWpGaD
Clodronate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000147	0.000555	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	0.000147	0.00108	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CTNNB1—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GCG—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000146	0.00107	CbGpPWpGaD
Clodronate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000145	0.000548	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000144	0.000544	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.000144	0.00106	CbGpPWpGaD
Clodronate—Urticaria—Epirubicin—pancreatic cancer	0.000144	0.000541	CcSEcCtD
Clodronate—SLC25A4—Disease—SMAD4—pancreatic cancer	0.000143	0.00105	CbGpPWpGaD
Clodronate—Abdominal pain—Epirubicin—pancreatic cancer	0.000143	0.000538	CcSEcCtD
Clodronate—SLC25A4—Disease—HES1—pancreatic cancer	0.00014	0.00103	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CD—pancreatic cancer	0.000139	0.00102	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatic cancer	0.000138	0.00101	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—STK11—pancreatic cancer	0.000137	0.001	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOTCH1—pancreatic cancer	0.000135	0.000992	CbGpPWpGaD
Clodronate—Urticaria—Doxorubicin—pancreatic cancer	0.000133	0.0005	CcSEcCtD
Clodronate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000132	0.000498	CcSEcCtD
Clodronate—SLC25A5—Metabolism—PIK3CG—pancreatic cancer	0.000132	0.000969	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000132	0.000966	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGF—pancreatic cancer	0.000131	0.000959	CbGpPWpGaD
Clodronate—Pruritus—Epirubicin—pancreatic cancer	0.000128	0.000482	CcSEcCtD
Clodronate—SLC25A5—Metabolism—PPARG—pancreatic cancer	0.000127	0.000935	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000127	0.000935	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000125	0.000918	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—RB1—pancreatic cancer	0.000125	0.000915	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	0.000124	0.00091	CbGpPWpGaD
Clodronate—Diarrhoea—Epirubicin—pancreatic cancer	0.000124	0.000466	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—CXCL8—pancreatic cancer	0.000123	0.000906	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—pancreatic cancer	0.000123	0.0009	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TERT—pancreatic cancer	0.000122	0.000899	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	0.000122	0.000892	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CB—pancreatic cancer	0.000121	0.000887	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—pancreatic cancer	0.00012	0.000879	CbGpPWpGaD
Clodronate—Pruritus—Doxorubicin—pancreatic cancer	0.000118	0.000446	CcSEcCtD
Clodronate—SLC25A4—Metabolism—TYMS—pancreatic cancer	0.000118	0.000864	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HIF1A—pancreatic cancer	0.000117	0.000859	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TSC2—pancreatic cancer	0.000117	0.000857	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CD—pancreatic cancer	0.000116	0.000853	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CD—pancreatic cancer	0.000116	0.000852	CbGpPWpGaD
Clodronate—Vomiting—Epirubicin—pancreatic cancer	0.000115	0.000433	CcSEcCtD
Clodronate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000114	0.000431	CcSEcCtD
Clodronate—SLC25A4—Disease—APOE—pancreatic cancer	0.000114	0.000839	CbGpPWpGaD
Clodronate—Rash—Epirubicin—pancreatic cancer	0.000114	0.000429	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—CTNNB1—pancreatic cancer	0.000114	0.000836	CbGpPWpGaD
Clodronate—Dermatitis—Epirubicin—pancreatic cancer	0.000114	0.000429	CcSEcCtD
Clodronate—SLC25A6—Metabolism—PIK3CG—pancreatic cancer	0.000111	0.000812	CbGpPWpGaD
Clodronate—Nausea—Epirubicin—pancreatic cancer	0.000107	0.000404	CcSEcCtD
Clodronate—SLC25A5—Disease—CTNNB1—pancreatic cancer	0.000107	0.000786	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—pancreatic cancer	0.000107	0.000784	CbGpPWpGaD
Clodronate—Vomiting—Doxorubicin—pancreatic cancer	0.000106	0.000401	CcSEcCtD
Clodronate—SLC25A4—Disease—NOTCH1—pancreatic cancer	0.000106	0.000774	CbGpPWpGaD
Clodronate—Rash—Doxorubicin—pancreatic cancer	0.000105	0.000397	CcSEcCtD
Clodronate—Dermatitis—Doxorubicin—pancreatic cancer	0.000105	0.000397	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000105	0.000768	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTEN—pancreatic cancer	0.000104	0.000766	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGF—pancreatic cancer	0.000102	0.000748	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CB—pancreatic cancer	0.000101	0.000743	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CB—pancreatic cancer	0.000101	0.000743	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—pancreatic cancer	0.0001	0.000736	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—pancreatic cancer	0.0001	0.000736	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	9.94e-05	0.00073	CbGpPWpGaD
Clodronate—Nausea—Doxorubicin—pancreatic cancer	9.93e-05	0.000374	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	9.75e-05	0.000716	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CD—pancreatic cancer	9.73e-05	0.000714	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SRC—pancreatic cancer	9.69e-05	0.000711	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—pancreatic cancer	9.58e-05	0.000703	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	9.52e-05	0.000698	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	9.49e-05	0.000696	CbGpPWpGaD
Clodronate—SLC25A5—Disease—STAT3—pancreatic cancer	9.34e-05	0.000685	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NRAS—pancreatic cancer	9.32e-05	0.000684	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	9.26e-05	0.00068	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	9.08e-05	0.000666	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CD—pancreatic cancer	9.07e-05	0.000666	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	9.01e-05	0.000661	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	9e-05	0.00066	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CTNNB1—pancreatic cancer	8.98e-05	0.000659	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	8.75e-05	0.000642	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTEN—pancreatic cancer	8.75e-05	0.000642	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTEN—pancreatic cancer	8.75e-05	0.000642	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—pancreatic cancer	8.68e-05	0.000637	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—pancreatic cancer	8.66e-05	0.000635	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CG—pancreatic cancer	8.64e-05	0.000634	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—pancreatic cancer	8.49e-05	0.000623	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CB—pancreatic cancer	8.48e-05	0.000622	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—pancreatic cancer	8.4e-05	0.000617	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—pancreatic cancer	8.34e-05	0.000612	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRSS1—pancreatic cancer	8.12e-05	0.000596	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SRC—pancreatic cancer	8.12e-05	0.000596	CbGpPWpGaD
Clodronate—PTGS2—Disease—ZNRF3—pancreatic cancer	8.12e-05	0.000596	CbGpPWpGaD
Clodronate—SLC25A5—Disease—KRAS—pancreatic cancer	8.02e-05	0.000588	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CB—pancreatic cancer	7.91e-05	0.00058	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—pancreatic cancer	7.83e-05	0.000575	CbGpPWpGaD
Clodronate—SLC25A6—Disease—STAT3—pancreatic cancer	7.83e-05	0.000574	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NRAS—pancreatic cancer	7.81e-05	0.000573	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	7.66e-05	0.000562	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CD—pancreatic cancer	7.6e-05	0.000557	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	7.43e-05	0.000545	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	7.41e-05	0.000544	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CA—pancreatic cancer	7.37e-05	0.000541	CbGpPWpGaD
Clodronate—PTGS2—Disease—DTX1—pancreatic cancer	7.34e-05	0.000539	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTEN—pancreatic cancer	7.33e-05	0.000538	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—pancreatic cancer	7.27e-05	0.000534	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	7.27e-05	0.000533	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—pancreatic cancer	7.26e-05	0.000532	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—pancreatic cancer	7.11e-05	0.000522	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CTNNB1—pancreatic cancer	7.01e-05	0.000514	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	6.92e-05	0.000508	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTEN—pancreatic cancer	6.83e-05	0.000501	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HRAS—pancreatic cancer	6.82e-05	0.0005	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PRSS1—pancreatic cancer	6.8e-05	0.000499	CbGpPWpGaD
Clodronate—SLC25A6—Disease—KRAS—pancreatic cancer	6.72e-05	0.000493	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CB—pancreatic cancer	6.62e-05	0.000486	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—pancreatic cancer	6.56e-05	0.000481	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.48e-05	0.000475	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—pancreatic cancer	6.34e-05	0.000465	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.3e-05	0.000462	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.24e-05	0.000458	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—pancreatic cancer	6.17e-05	0.000453	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—pancreatic cancer	6.17e-05	0.000453	CbGpPWpGaD
Clodronate—PTGS2—Disease—DTX4—pancreatic cancer	6.15e-05	0.000451	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—pancreatic cancer	6.11e-05	0.000448	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	6.1e-05	0.000448	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NRAS—pancreatic cancer	6.1e-05	0.000447	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.08e-05	0.000446	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—pancreatic cancer	6.02e-05	0.000442	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP2R5B—pancreatic cancer	5.98e-05	0.000439	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ARG2—pancreatic cancer	5.89e-05	0.000432	CbGpPWpGaD
Clodronate—PTGS2—Disease—HEY2—pancreatic cancer	5.76e-05	0.000423	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTEN—pancreatic cancer	5.72e-05	0.00042	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HRAS—pancreatic cancer	5.71e-05	0.000419	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—pancreatic cancer	5.68e-05	0.000417	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—pancreatic cancer	5.66e-05	0.000416	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.64e-05	0.000414	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—pancreatic cancer	5.55e-05	0.000407	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.49e-05	0.000403	CbGpPWpGaD
Clodronate—PTGS2—Disease—HEY1—pancreatic cancer	5.33e-05	0.000391	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KRAS—pancreatic cancer	5.25e-05	0.000385	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—pancreatic cancer	5.17e-05	0.000379	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TYMP—pancreatic cancer	5.15e-05	0.000378	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.06e-05	0.000371	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—pancreatic cancer	5.04e-05	0.00037	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.04e-05	0.00037	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—pancreatic cancer	5.04e-05	0.00037	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.94e-05	0.000363	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—pancreatic cancer	4.82e-05	0.000354	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAG2—pancreatic cancer	4.73e-05	0.000347	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.71e-05	0.000346	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.67e-05	0.000343	CbGpPWpGaD
Clodronate—PTGS2—Disease—MEN1—pancreatic cancer	4.66e-05	0.000342	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A2—pancreatic cancer	4.63e-05	0.00034	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HRAS—pancreatic cancer	4.46e-05	0.000327	CbGpPWpGaD
Clodronate—PTGS2—Disease—SHH—pancreatic cancer	4.45e-05	0.000326	CbGpPWpGaD
Clodronate—PTGS2—Disease—IAPP—pancreatic cancer	4.39e-05	0.000322	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.29e-05	0.000315	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.25e-05	0.000312	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—pancreatic cancer	4.22e-05	0.00031	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSPA1B—pancreatic cancer	4.22e-05	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLP1R—pancreatic cancer	4.15e-05	0.000305	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.15e-05	0.000305	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DPYD—pancreatic cancer	4.09e-05	0.0003	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—pancreatic cancer	4.04e-05	0.000296	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—pancreatic cancer	3.94e-05	0.000289	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A2—pancreatic cancer	3.88e-05	0.000284	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.84e-05	0.000281	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAG1—pancreatic cancer	3.77e-05	0.000277	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.7e-05	0.000272	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD44—pancreatic cancer	3.58e-05	0.000263	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSPA1A—pancreatic cancer	3.56e-05	0.000261	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.51e-05	0.000257	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.37e-05	0.000247	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—pancreatic cancer	3.3e-05	0.000242	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD44—pancreatic cancer	3e-05	0.00022	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.94e-05	0.000216	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCG—pancreatic cancer	2.88e-05	0.000211	CbGpPWpGaD
Clodronate—PTGS2—Disease—SMAD4—pancreatic cancer	2.83e-05	0.000208	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—pancreatic cancer	2.76e-05	0.000203	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STK11—pancreatic cancer	2.71e-05	0.000199	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.54e-05	0.000186	CbGpPWpGaD
Clodronate—PTGS2—Disease—TERT—pancreatic cancer	2.42e-05	0.000178	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TYMS—pancreatic cancer	2.33e-05	0.000171	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIF1A—pancreatic cancer	2.32e-05	0.00017	CbGpPWpGaD
Clodronate—PTGS2—Disease—TSC2—pancreatic cancer	2.31e-05	0.000169	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—pancreatic cancer	2.26e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOTCH1—pancreatic cancer	2.09e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGF—pancreatic cancer	2.02e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—pancreatic cancer	1.89e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CD—pancreatic cancer	1.79e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.79e-05	0.000131	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—pancreatic cancer	1.71e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—pancreatic cancer	1.65e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CB—pancreatic cancer	1.56e-05	0.000115	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CD—pancreatic cancer	1.5e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—CTNNB1—pancreatic cancer	1.39e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTEN—pancreatic cancer	1.35e-05	9.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CB—pancreatic cancer	1.31e-05	9.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—pancreatic cancer	1.25e-05	9.19e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—pancreatic cancer	1.21e-05	8.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NRAS—pancreatic cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTEN—pancreatic cancer	1.13e-05	8.3e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—pancreatic cancer	1.12e-05	8.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—pancreatic cancer	1.12e-05	8.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—pancreatic cancer	1.1e-05	8.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KRAS—pancreatic cancer	1.04e-05	7.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—pancreatic cancer	9.53e-06	6.99e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HRAS—pancreatic cancer	8.82e-06	6.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—pancreatic cancer	7.98e-06	5.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—pancreatic cancer	7.79e-06	5.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—pancreatic cancer	6.52e-06	4.78e-05	CbGpPWpGaD
